It specifically inhibited the transactivation activity of PPARγ, but not that of PPARα, β/δ and LXR α,β, by repressing the adipocyte differentiation and ameliorating obesity, insulin resistance, steatosis and hyperlipidemia in diet-induced obesity mice. Here, PPARG is linked to obesity disorder.